Feasibility of Emulating Clinical Trials Supporting US FDA Supplemental Indication Approvals of Drugs and Biologics

This cross-sectional study evaluates the supporting clinical trials for supplemental new drug applications and supplemental biologics license applications from 2017 to 2019.

Automated summary

This study evaluates the clinical trial support for supplemental new drug applications and supplemental biologics license applications from 2017 to 2019.